How to communicate evidence to patients
Drug and Therapeutics Bulletin · 2019-08 · 57 (8) · 119-124
DOI: 10.1136/dtb.2019.000008 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug and Therapeutics Bulletin, online erschienen am 25.07.2019. Verfasst von Alexandra L J Freeman. Beteiligte Einrichtung: Winton Centre for Risk and Evidence Communication, Centre for Mathematical Sciences, University of Cambridge, Cambridge, UK alex.freeman@maths.cam.ac…. Hauptthemen laut MEDLINE: Communication, Decision Making. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
All medical treatments have potential harms as well as benefits, and it’s vital that everyone has a good understanding of what these might be, how dramatic they might be, and how likely. In fact, in the UK, the Montgomery judgement in the supreme court in 2015 has made it a legal necessity for patients to be given comprehensible, personally relevant information about all reasonable treatment options – including none. So, how should we ensure this good, clear communication of relevant evidence?
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Winton Centre for Risk and Evidence Communication, Centre for Mathematical Sciences, University of Cambridge, Cambridge, UK alex.freeman@maths.cam.ac.uk.
ORCID-Profile: Alexandra L J Freeman
Zitieren
APA
Freeman, A. L. J. (2019). How to communicate evidence to patients. Drug and Therapeutics Bulletin, 57(8), 119-124. https://doi.org/10.1136/dtb.2019.000008
Vancouver
Freeman ALJ. How to communicate evidence to patients. Drug and Therapeutics Bulletin. 2019;57(8):119-124. doi:10.1136/dtb.2019.000008
BibTeX
@article{Freeman2019,
author = {Freeman, Alexandra L J},
title = {How to communicate evidence to patients},
journal = {Drug and Therapeutics Bulletin},
year = {2019},
volume = {57},
number = {8},
pages = {119--124},
doi = {10.1136/dtb.2019.000008}
}
EUVIMED